Hwaseong-si, South Korea

Euh Lim Oh

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Hanam-si, KR (2016)
  • Seoul, KR (2016)
  • Hwaseong-si, KR (2018 - 2022)
  • Gyeonggi-do, KR (2019 - 2023)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Euh Lim Oh: Innovator in Immunostimulatory IL-2 Analogs

Introduction

Euh Lim Oh is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology, particularly through his work on interleukin-2 (IL-2) analogs. With a total of 11 patents to his name, his innovations have the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Euh Lim Oh's latest patents focus on immunostimulating IL-2 analogs. These patents disclose modifications to interleukin-2 alpha receptors, enhancing their binding affinity for interleukin-2 beta receptors. His work on these analogs aims to improve the efficacy of IL-2 in therapeutic applications, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Euh Lim Oh has worked with notable companies such as Hanmi Pharm Co., Ltd. and Hanmi Science Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Euh Lim Oh has collaborated with esteemed colleagues, including Se Chang Kwon and Sung Youb Jung. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Euh Lim Oh's contributions to the field of immunology through his patents on IL-2 analogs highlight his role as a key innovator. His work not only advances scientific understanding but also holds promise for future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…